Efficacy and safety of zuranolone in major depressive disorder: a meta-analysis of factor effect and dose-response analyses

BACKGROUND: Zuranolone is recognised as a promising antidepressant agent. Our study aimed to investigate the efficacy and safety of zuranolone in treating major depressive disorder (MDD). METHODS: A systematic review was conducted by searching major databases from inception to August 20, 2023 (INPLA...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yu-Wei, Tu, Yu-Kang, Hung, Kuo-Chuan, Liang, Chih-Sung, Tseng, Ping-Tao, Lin, Pao-Yen, Chia-Cheng Lai, Edward, Hsu, Chih-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690540/
https://www.ncbi.nlm.nih.gov/pubmed/38045802
http://dx.doi.org/10.1016/j.eclinm.2023.102308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690540/
https://www.ncbi.nlm.nih.gov/pubmed/38045802
http://dx.doi.org/10.1016/j.eclinm.2023.102308

Ejemplares similares